Article Information
History
- November 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ashwin V Venkataraman1,2,13,
- Courtney Bishop3,
- Ayla Mansur3,13,
- Gaia Rizzo1,3,
- Yvonne Lewis3,
- Ece Kocagoncu5,
- Anne Lingford-Hughes1,
- Mickael Huiban3,13,
- Jan Passchier3,13,
- James B Rowe5,13,
- Hideo Tsukada6,13,
- David J. Brooks7,13,
- Laurent Martarello8,13,
- Robert A. Comley9,13,
- Laigao Chen10,13,
- Richard Hargreaves11,13,
- Adam J. Schwarz12,13,
- Roger N. Gunn1,3,13,
- Eugenii A. Rabiner3,4,13 and
- Paul M Matthews1,2,13,*
- 1Department of Brain Sciences, Imperial College London; London, UK
- 2UK Dementia Research Institute at Imperial College London; London, UK
- 3Invicro LLC.; London, UK
- 4King’s College London; London, UK
- 5University of Cambridge; Cambridge, UK
- 6Hamamatsu Photonics; Hamamatsu,Japan
- 7University of Newcastle upon Tyne, UK and Aarhus University; DK
- 8Biogen, Cambridge; USA
- 9AbbVie, Chicago; USA
- 10Pfizer Inc., Cambridge; USA
- 11Bristol Myers Squibb; New York, USA
- 12Takeda Pharmaceuticals Ltd; Cambridge, USA
- 13MINDMAPS Consortium
- ↵*Address for correspondence:
Prof. Paul M. Matthews, E515, Department of Brain Sciences, Imperial College London, Hammersmith Hospital, DuCane Road, London WC12 0NN, Tel: 0044 207 594 2612, p.matthews{at}imperial.ac.uk